Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Manunta

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Experimental Gerontology|January 12, 2026
Unmasking malnutrition through soluble RAGE: A biomarker-guided insight from FRASNETSarah Damanti, Clara Sciorati, Amanda Avola, et al.
Frontiers in Psychiatry|April 27, 2026
Association between baseline circulating FGF21 levels and depressive symptoms at follow up in older adults: evidence from the FRASNET cohortSarah Damanti, Clara Sciorati, Amanda Avola, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2014
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish populationYan-Ping Liu, Yu-Mei Gu, Lutgarde Thijs, et al.
Mechanisms of Ageing and Development|November 13, 2025
Circulating mitokines GDF-15 and FGF21 are associated with frailty, sarcopenia, and malnutrition in older adults: Evidence from the FRASNET studySarah Damanti, Clara Sciorati, Rebecca De Lorenzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Genetic burden of common variants in progressive and bout-onset multiple sclerosisMelissa Sorosina, Paola Brambilla, Ferdinando Clarelli, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.
BMC Genetics|October 3, 2015
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish populationWen-Yi Yang, Thibault Petit, Lutgarde Thijs, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2019
Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF StudyRoberto Bigazzi, Laura Zagato, Chiara Lanzani, et al.
Nature Communications|May 24, 2017
Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1Francesca Pasutto, Matthias Zenkel, Ursula Hoja, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Experimental Gerontology|January 12, 2026
Unmasking malnutrition through soluble RAGE: A biomarker-guided insight from FRASNETSarah Damanti, Clara Sciorati, Amanda Avola, et al.
Frontiers in Psychiatry|April 27, 2026
Association between baseline circulating FGF21 levels and depressive symptoms at follow up in older adults: evidence from the FRASNET cohortSarah Damanti, Clara Sciorati, Amanda Avola, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2014
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish populationYan-Ping Liu, Yu-Mei Gu, Lutgarde Thijs, et al.
Mechanisms of Ageing and Development|November 13, 2025
Circulating mitokines GDF-15 and FGF21 are associated with frailty, sarcopenia, and malnutrition in older adults: Evidence from the FRASNET studySarah Damanti, Clara Sciorati, Rebecca De Lorenzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Genetic burden of common variants in progressive and bout-onset multiple sclerosisMelissa Sorosina, Paola Brambilla, Ferdinando Clarelli, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.
BMC Genetics|October 3, 2015
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish populationWen-Yi Yang, Thibault Petit, Lutgarde Thijs, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2019
Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF StudyRoberto Bigazzi, Laura Zagato, Chiara Lanzani, et al.
Nature Communications|May 24, 2017
Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1Francesca Pasutto, Matthias Zenkel, Ursula Hoja, et al.
Pageof 15